MetaReal (6182) · RiskFirst stated

Delays, Interruptions and Cost Overruns in Machine Translation-Related R&D

First written in FY2020. . Latest entry: FY2020.

1entries

1years

0from disclosures

How it moved

Same theme, other companies

Risk of Delayed New Product Launches Due to R&D DelaysA theme 72 companies write about · 72 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2025: 3 of 22 companies on the "Worse" side.

4 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.

Showing 14 of the 72 companies compared. The sentences above are computed from all 72.

Full recordFilings, disclosures and news, newest first

FY2020First statedAnnual report
「If research and development is delayed rather than proceeding as scheduled, or if development is interrupted or discontinued, or development costs exceed expectations because of sudden changes in the business environment or unforeseen circumstances, this could affect the performance of the MT and crowdsourcing businesses.」
Delays, interruption, discontinuation and development costs exceeding expectations are identified as performance risks for research and development of machine translation-related systems.

Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next

No upcoming earnings preview for MetaReal yet.

News

No news is linked to this thread yet. When an article touches it, it will appear here by date.